PARA HealthCare Analytics Weekly eJournal February 26, 2020

February 26, 2020

PARA

WeeklyeJOURNAL NEWS FOR HEALTHCARE DECISION MAKERS

Page

5

Page

M ech an ical Th r om bect om y

PARA COM PANY NEWS

SERVICES

ABOUT PARA

CONTACT US

FAST LINKS

-

24

Page

8

Labor at or y Tr avel Allow an ce Paym en t s

Device Cr edit s - Disch ar ge St at u s Codes 81-95 - Complicated Bladder Stone - Gu idelin es For Locu m Ten en s Billin g - Transforming Bad Debt Into Revenue - Device Cat egor y Codes For Pass-Th r ou gh Paym en t s - 2020 Coverage For Extravascular ICD Clinical Trial Claims - Codin g For Cor on avir u s - Payment Denials: How To Maximize Collections

Administration: Pages 1-58 HIM /Coding Staff: Pages 1-58 Providers: Pages 5,7,12,24,27,31 Admitting: Page 2 Cardiology: Pages 5,26,27 Urology: Pages 7,25

-

Laboratory Svcs: Page 8 Finance: Pages 8,12,17,33,40 M edical Offices: Page 12 Surgical Services: Page 24 Revenue Cycle: Page 30 Infectious Diseases: Page 31

© PARA Healt h Car e An alyt ics an HFRI Company CPT® is a r egist er ed t r adem ar k of t h e Am er ican M edical Associat ion

PARA Weekly eJournal: February 26, 2020

DISCHARGE STATUS CODES 81-95

Does PARA have any information on when to report discharge status code range 81-95?

Answer: Patient discharge status code range 81-95 are utilized to note that there is a planned re-admission. The codes correlate with the established ?Base codes? 01-06, 21, 43,61-66, and 70. The patient discharges status code range from 81-95 are effective for dates of service on or after October 13, 2013. These codes apply to the original discharge claim.

These codes are not intended to replace any old discharge codes but the codes are only to be reported if there is a planned acute care re-admission in the future. CMS defines a re-admission as ?An intentional re-admission after discharge from an acute care hospital that is a scheduled part of the patient?s plan of care.?

As referenced in the UB Editor regarding these codes: ?CMS has an algorithm to identify readmissions and will continue to use it. CMS will accept any codes submitted, but they will not be incorporated into the readmission algorithm. There is no defined time period of a readmission.

A readmission is defined as ?an intentional readmission after discharge from an acute care hospital that is a scheduled part of the patient?s plan of care.? These codes would be more for internal records and as a comparison to Medicare rates of readmissions. The issue of planned versus unplanned readmissions is not considered by CMS for Medicare patients. (NUBC July 31-August 1, 2012 Conference Call Minutes)? https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/ MLNMattersArticles/Downloads/SE1411.pdf

2

PARA Weekly eJournal: February 26, 2020

DISCHARGE STATUS CODES 81-95

A list of the Uniform Billing Committee?s discharge codes is available on the PARA Data Editor Calculator tab; enter ?Discharge? in the description field on the left, and select the UB04 report on the right:

https://www.cgsmedicare.com/parta/pubs/news/2016/11/cope1187.html

3

PARA Weekly eJournal: February 26, 2020

DISCHARGE STATUS CODES 81-95

4

PARA Weekly eJournal: February 26, 2020

MECHANICAL THROMBECTOMY

What are the appropriate codes for a mechanical thrombectomy. We are considering 36224 w/ modifier XU, 61645, 76377.

Answer: Report CPT速 code 61645 for the percutaneous mechanical thrombectomy of the left middle cerebral artery (M1 segment) and the left external carotid artery.

The selective catheterizations are included along with the imaging. The left external carotid artery percutaneous mechanical thrombectomy is included in the left middle cerebral artery thrombectomy.

Please refer to the Coding Clinic for HCPCS 1st Qtr 2016 reference and Dr Z's Interventional Radiology Code Book pages 315-332, which discusses mechanical thrombectomy and the services included in CPT速 code 61645. CPT速 codes 36224 and 36227 are components of 61645 per OCE/NCCI edits and not separately reported. There is no documentation of a diagnostic angiogram.

The clot was already known from the imaging performed before the thrombectomy.

The documentation provided does not support 3-D rendering, therefore CPT速 code 76377 should not be reported separately.

Please refer to the PARA Data Editor code descriptions and PARA Data Editor CCI edits.

5

PARA Weekly eJournal: February 26, 2020

MECHANICAL THROMBECTOMY

Coding Clinic for HCPCSÂŽ 1st Q 2016 pages 1-3 Treatment of the occlusion of the intracranial artery involves destruction, removal or dissolution of the clot in order to improve blood supply to the area. The intracranial arteries are divided into three vascular territories which include: right carotid circulation, left carotid circulation, and vertebro-basilar circulation.

CPTÂŽ code 61645 is reported for the revascularization of the intracranial artery(ies) by any method including mechanical thrombectomy, which is accomplished with the use of devices inserted through a catheter in order to break up and remove the clot from the affected vessel(s) or the infusion of drugs (thrombolysis) in order to dissolve the clot and improve blood flow to the area.

The following procedure(s) and service(s) are included in codes 61645, 61650 and 61651: - Selective catheterization - Diagnostic angiography - All subsequent angiography including associated radiological supervision and interpretation within the treated vascular territory - Fluoroscopic guidance - Neurologic and hemodynamic monitoring of the patient - Closure of the arteriotomy by manual pressure, an arterial closure device, or suture

Dr Z's Interventional Radiology Code Book pages 315-332 #37. If embolectomy or thrombectomy of an intracranial artery is performed with a Merci Retrieval, Penumbra (3D, ACE 68), Trevo, Solitaire (Platinum Hero), MindFrame Capture LP, EmboTrap revascularization device, or other intracerebral thrombectomy device, use code 61645 per cerebral territory. These codes include ipsilateral catheter placement, imaging, the use of thrombolytics, and follow-up angiography. #41. Codes 61645, 61650, and 61651 describe arterial procedures and bundle catheter placement, diagnostic imaging, guidance, and follow-up (completion) imaging in the same cerebral territory. #42. Use code 61645 for catheter-directed cerebral thrombolytic infusion therapy (per territory). This includes thrombectomy and any means to revascularize an acutely occluded intracranial artery. Code 61645 can also be submitted if only thrombectomy is performed without thrombolytic infusion. This code is for revascularization by any method to treat thrombus/embolus/occlusion of cerebral arteries and bundles intracranial angioplasty (61630), intracranial stent placement (61635), and intracranial vasospasm therapy (61650) in the same cerebral territory.#52. For codes 61645 (intracranial arterial revascularization) and 61650/61651 (intracranial arterial continuous or intermittent non-thrombolytic infusion therapy), there are three arterial territories: the right carotid, left carotid, and vertebrobasilar.

Only one code can be submitted per territory. These include catheter placement, diagnostic imaging, and follow-up of the ipsilateral territory.

6

PARA Weekly eJournal: February 26, 2020

COMPLICATED BLADDER STONE CASE

I have a complicated bladder stone case that I am working on and I'm seeking some much needed direction. I realize this is not a typical case and the physician did a lot of additional work. How should this account be coded?

First question, can we bill for each of the stones individually? Also, the surgeon said, "The case is really more consistent with a percutaneous nephrolithotomy than it is with a cystolithalopaxy (take a look at the technique)."

Second question, can I code for percutaneous nephrolithotomy when the patient already had a suprapubic tube which was used for access to the bladder, therefore the physician did not have to create an access?

Answer: Report 53899, unlisted urinary procedure. The report states an existing suprapubic catheter is used, which is a portal into the bladder. The physician is basically bypassing the occluded urethra. After dilation of this tract, the physician used a nephroscope to advance into the bladder.

The bladder is drained and a "ShockPulse" device is used to fragment the stones. The bladder is drained of debris and larger stones are removed. There is currently no CPT® code that incorporates this technique and therefore it would be reported to unlisted. Do not report this code for each stone.

With other codes for stone removal, the CPT® code is only reported once for the largest stone removed, not one code for each stone. The same would apply in this case. Please refer to the PARA Data Editor reference CPT® Assistant, June 2009 Page: 10, the code "is based on the size of the largest stone removed in linear measurement."

7

PARA Weekly eJournal: February 26, 2020

OIG CRITICIZES LABORATORY TRAVEL ALLOWANCE PAYMENTS

In December of 2019, the Office of the Inspector General published a report critical of one MAC?s performance in paying for travel allowances for phlebotomy services.

The report alleged that the MAC did not sufficiently monitor provider use of the reimbursement codes. As a result, providers nationwide can expect MACs to be more aggressive in auditing claims which report P9603 or P9604 in the future.

A link and an excerpt from the OIG report ?NOVITAS SOLUTIONS, INC. NEEDS ENHANCED GUIDANCE AND PROVIDER EDUCATION RELATED TO PHLEBOTOMY TRAVEL ALLOWANCE? is provided: https://oig.hhs.gov/oas/reports/region6/61704002.pdf NO DOCUMENTATION TO SUPPORT SPECIMEN COLLECTION Payments to Medicare providers should not be made unless the provider has furnished information necessary to the MAC to determine the amount owed to the provider.

The Manual states that the travel allowance should be prorated by dividing the mileage by the total number of patients from whom specimen draws or pickups were made in the same trip.

Each January, CMS publishes the national rate of payment for laboratory specimen collection services. The per-mile rate for P9603 is based on the IRS standard mileage rate for business plus an allowance to cover technician labor expense. However, Medicare Administrative Contractors may pay more than the minimum rate if local conditions warrant it.

8

PARA Weekly eJournal: February 26, 2020

OIG CRITICIZES LABORATORY TRAVEL ALLOWANCE PAYMENTS

MACs have the option of establishing a higher per mile rate in excess of the minimum set forth by CMS each year if local conditions warrant it. Medicare may review and update the minimum mileage rate throughout the year, as well as in conjunction with the Clinical Laboratory Fee Schedule (CLFS), as needed.

The CMS transmittal announcing 2020 rates was released on January 17, 2020, with rates retroactive to January 1, 2020.

Here is a link: https://www.cms.gov/files/document/mm11641.pdf Each MAC may, at its discretion, choose to pay either a mileage basis or a flat rate per trip. Many MACs have established local policy to pay only on a flat-rate basis, because audits have shown that some laboratories abused the per mileage fee basis by claiming travel mileage in excess of the minimum distance necessary for a laboratory technician to travel for specimen collection,.

Another MAC, WPS, published the following tips for documentation in support of travel allowances: Laboratory Services - Clear indication of patient name, date of birth, and date of service - Lab results for date(s) of service billed - Signed and dated physician order or progress/clinic/visit notes that clearly document the specific service(s) to be performed - Documentation to support the medical necessity of ordered test(s) - Medical diagnosis - Signs and symptoms (rationale for lab performed) - If travel allowance for specimen collection is billed: - Number of collections performed per trip (for both Medicare and non-Medicare patients) to compute the Medicare prorated fee - Documentation of miles actually traveled - Documentation supporting that patient is homebound or nursing home bound 9

PARA Weekly eJournal: February 26, 2020

OIG CRITICIZES LABORATORY TRAVEL ALLOWANCE PAYMENTS

The Medicare Claims Processing Manual offers the following guidance on claiming reimbursement for travel. Excerpts from Chapter 16 of the Manual are provided here: https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c16.pdf# 60.2 - Travel Allowance The Medicare Claims Processing Manual provides the following direction on calculating the mileage for lab specimen collection: Per Mile Travel Allowance (P9603) - The minimum ?per mile travel allowance? is $0.99. The per mile travel allowance is to be used in situations where the average trip to patients?homes is longer than 20 miles round trip, and is to be pro-rated in situations where specimens are drawn or picked up from non-Medicare patients in the same trip, one way, in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually traveled (A/B MAC (B) allowance on per mile basis); or - The per mile allowance was computed using the Federal mileage rate plus an additional 45 cents a mile to cover the technician?s time and travel costs. A/B MACs (B) have the option of establishing a higher per mile rate in excess of the minimum ($0.99 a mile in CY 2016) if local conditions warrant it.

The minimum mileage rate will be reviewed and updated in conjunction with the clinical lab fee schedule as needed. At no time will the laboratory be allowed to bill for more miles than are reasonable or for miles not actually traveled by the laboratory technician.

Example 1: In CY 2016, a laboratory technician travels 60 miles round trip from a lab in a city to a remote rural location, and back to the lab to draw a single Medicare patient?s blood. The total reimbursement would be $59.40 (60 miles x $0.99 cents a mile), plus the specimen collection fee.

Example 2: In CY 2016, a laboratory technician travels 40 miles from the lab to a Medicare patient?s home to draw blood, and then travels an additional 10 miles to a non-Medicare patient?s home and then travels 30 miles to return to the lab. The total miles traveled would be 80 miles. The claim submitted would be for one half of the miles traveled or $39.60 (40 x $0.99), plus the specimen collection fee.

Flat Rate (P9604) The CMS will pay a minimum of $10.30 (based on CY 2019) one way flat rate travel allowance. The flat rate travel allowance is to be used in areas where average trips are less than 20 miles round trip. The flat rate travel fee is to be pro-rated for more than one blood drawn at the same address, and for stops at the homes of Medicare and non-Medicare patients. The laboratory does the pro-ration when the claim is submitted based on the number of patients seen on that trip.

The specimen collection fee will be paid for each patient encounter.

10

PARA Weekly eJournal: February 26, 2020

OIG CRITICIZES LABORATORY TRAVEL ALLOWANCE PAYMENTS

This rate is based on an assumption that a trip is an average of 15 minutes and up to 10 miles one way. It uses the Federal mileage rate and a laboratory technician?s time of $17.66 an hour, including overhead.

A/B MACs (B) have the option of establishing a flat rate in excess of the minimum of $9.90, if local conditions warrant it. The minimum national flat rate will be reviewed and updated in conjunction with the clinical laboratory fee schedule, as necessitated by adjustments in the Federal travel allowance and salaries.

The claimant identifies round trip travel by use of the LR modifier.

Example 3: A laboratory technician travels from the laboratory to a single Medicare patient?s home and returns to the laboratory without making any other stops. The flat rate would be calculated as follows: 2 x $9.90 for a total trip reimbursement of $19.80, plus the specimen collection fee.

Example 4: A laboratory technician travels from the laboratory to the homes of five patients to draw blood, four of the patients are Medicare patients and one is not. An additional flat rate would be charged to cover the 5 stops and the return trip to the lab (6 x $9.90 = $59.40). Each of the claims submitted would be for $11.88 ($59.40/5 = $11.88). Since one of the patients is non-Medicare, four claims would be submitted for $11.88 each, plus the specimen collection fee for each.

Example 5: A laboratory technician travels from a laboratory to a nursing home and draws blood from 5 patients and returns to the laboratory. Four of the patients are on Medicare and one is not. The $9.90 flat rate is multiplied by two to cover the return trip to the laboratory (2 x $9.90 = $19.80) and then divided by five (1/5 of $19.80 = $3.96). Since one of the patients is non-Medicare, four claims would be submitted for $3.96 each, plus the specimen collection fee.

If an A/B MAC (B) determines that it results in equitable payment, the A/B MAC (B) may extend the former payment allowances for additional travel (such as to a distant rural nursing home) to all circumstances where travel is required. This might be appropriate, for example, if the A/B MAC (B)?s former payment allowance was on a per mile basis. Otherwise, it should establish an appropriate allowance and inform the suppliers in its service area. If an A/B MAC (B) decides to establish a new allowance, one method is to consider developing a travel allowance consisting of: - - The current Federal mileage allowance for operating personal automobiles, plus a personnel allowance per mile to cover personnel costs based upon an estimate of average hourly wages and average driving speed A/B MACs (B) must prorate travel allowance amounts claimed by suppliers by the number of patients (including Medicare and non-Medicare patients) from whom specimens were drawn on a given trip.

The A/B MAC (B) may determine that payment in addition to the routine travel allowance determined under this section is appropriate if: - The patient from whom the specimen must be collected is in a nursing home or is homebound; and - The clinical laboratory tests are needed on an emergency basis outside the general business hours of the laboratory making the collection - Subsequent updated travel allowance amounts will be issued by CMS via Recurring Update Notification (RUN) on an annual basis.

11

PARA Weekly eJournal: February 26, 2020

GUIDELINES FOR LOCUM TENENS AND RECIPROCAL BILLING

Locum Tenensis a Latin phrase that means ?holding a place.?In the medical field, locum tenen is a term used for a physician who temporarily substitutes for another physician.

A locum tenen, or fee-for-time physician, may provide temporary services for the physician who is out due to illness, vacation, pregnancy, continuing education or military service.

Commonly, locum tenens do not have practices of their own and instead work under a staffing agency. We will discuss how to use the modifiers Q5 and Q6 to report substitute physicians.

A locum tenen physician does not have to enroll in Medicare, nor does he/she have to be the same specialty as the physician for whom he/she is substituting.

The locum tenen must have an NPI and an unrestricted license in the state that he or she is practicing. Per the Social Security Act, Section 1842(b) (6) (D), Medicare pays a physician for physician?s services.

Therefore, services furnished by non-physician practitioners (i.e., nurse practitioners and physician assistants) may not be billed using the locum tenen provision.The physician must be an MD, DO, or podiatrist (see page 4 for discussion of special circumstances that apply to physical therapists.) https://www.ssa.gov/OP_Home/ssact/title18/1842.htm ?(D) payment may be made to a physician for physicians?services (and services furnished incident to such services) furnished by a second physician to patients of the first physician if (i) the first physician is unavailable to provide the services; (ii) the services are furnished pursuant to an arrangement between the two physicians that (I) is informal and reciprocal, or (II) involves per diem or other fee-for-time compensation for such services; (iii) the services are not provided by the second physician over a continuous period of more than 60 days or are provided over a longer continuous period during all of which the first physician has been called or ordered to active duty as a member of a reserve component of the Armed Forces; and (iv) the claim form submitted to the carrier for such services includes the second physician?s unique identifier (provided under the system established under subsection (r)) and indicates that the claim meets the requirements of this subparagraph for payment to the first physician. No payment which under the preceding sentence may be made directly to the physician or other person providing the service involved (pursuant to an assignment described in subparagraph (B)(ii) of paragraph (3)) shall be made to anyone else under a reassignment or power of attorney (except to an employer or entity as described in subparagraph (A) of such sentence); but nothing in this subsection shall be construed (i) to prevent the making of such a payment in accordance with an assignment from the individual to whom the service was provided or a reassignment from the physician or other person providing such service if such assignment or 12

PARA Weekly eJournal: February 26, 2020

GUIDELINES FOR LOCUM TENENS AND RECIPROCAL BILLING

agent does so pursuant to an agency agreement under which the compensation to be paid to the agent for his services for or in connection with the billing or collection of payments due such physician or other person under this title is unrelated (directly or indirectly) to the amount of such payments or the billings therefor, and is not dependent upon the actual collection of any such payment.?

Medicare Rules for billing under Fee-For-Time (formerly referred to as Locum Tenen) arrangements: - Before the physician may bill for services provided by the locum tenen, the physician must ensure he/she has the following documents on file in his/her office and available upon request: - A copy of the locum tenen?s license and NPI - Documentation indicating the reason the physician is unavailable - An agreement or contract that describes the fee-for-time or per diem payment arrangements with the locum tenen as an independent contractor - The regular physician may submit a claim, using his or her NPI, for services furnished by the locum tenen while the regular physician was out due to illness, pregnancy, continuing education, vacation, or military service.

Medicare requires claims for locum tenen services clearly indicate that a substitute physician provided the services listed on the claim by using modifier Q6 after the procedure code in box 24D of the CMS billing form. The Q6 modifier attests that documentation for the locum tenen is on file with the regular physician and that the services billed comply with the correct use of the locum tenen provision. Falsely certifying the requirements is subject to civil and/or criminal penalties of fraud

- The Locum Tenens physician must be paid using a per diem or a fee-for-time (hourly) method - The locum tenen may provide coverage for no longer than a 60-day continuous period. The time begins on the first day the locum tenen started and must end 60 days after initiation. If the physician returns, even for one day, the 60-day limit resets - The only exception to the 60-day limitation, according to Section 116 of Medicare, Medicaid, and SCHIP Extension Act of 2007, is if the regular physician is called to active duty military service. dhttps://www.congress.gov/110/plaws/publ173/PLAW-110publ173.pdf 13

PARA Weekly eJournal: February 26, 2020

GUIDELINES FOR LOCUM TENENS AND RECIPROCAL BILLING

- A physician may employ more than one locum tenen during the same 60-day consecutive period.However, only one locum tenen may work for the physician per day - The locum tenen: - May not cover on-call or part-time work for physicians - May not provide services for a deceased physician - May not be contracted to offer extended hours or to address high volume for the practice - May not provide service while a new physician is waiting for the completion of credentialing or enrollment - May not bill postop services with a Q6 modifier if the services are included in the global surgery fee - May provide up to 60 continuous days after a physician retires or resigns. If necessary, another locum tenen, with a different 60-day period, may extend coverage.However, the retiring or resigning physician must notify Medicare provider enrollment of his/her departure within 90 days. Once Medicare is notified, the locum tenen may no longer bill using that physician?s NPI - May be employed by a group practice for up to 60 days after a physician leaves the group The CMS Claims Manual, 30.2.11 discusses claim submission Fee-For-Time Arrangements: https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c01.pdf

Report the Q6 modifier for the first 60-day continuous period of the locum tenen. Should a locum tenen services extend beyond day 60, he/she must bill under his/her own NPI. Locum Tenen physicians will affect the quality payment program and MIPs score of the absent physician or physician group.

Reciprocal Billing Arrangements Physicians may often provide coverage for each other?s covered services using a reciprocal billing arrangement. When accepted for Medicare assignment, a physician may bill under his/her NPI for services provided by a substitute physician who has agreed to occasional reciprocal agreements. The physician may not provide services to patients longer than a 60-day continuous period.

Reciprocal billing arrangements may include multiple physicians, and the arrangement doesn?t need to be formalized in writing.

Also, as long a Medicare payment is not reassigned to a medical group (through a CMS 855-R), a medical group may submit claims using modifier Q5 with the regular physician NPI when he/she is unavailable.When the regular physician is unavailable to provide the service, he/she may submit a claim for services provided by the substitute physician by using modifier Q5 with the procedure code. If the substitute physician is providing only postop services that are covered by the global fee, the modifier Q5 is not required.

14

PARA Weekly eJournal: February 26, 2020

GUIDELINES FOR LOCUM TENENS AND RECIPROCAL BILLING

The Medicare Claims Processing Manual, 30.2.10 discusses claim submission under Reciprocal Billing Arrangements: https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c01.pdf

Following the 21st Century Cures Act (Public Law 114-255, Section 16006), reciprocal billing and locum tenens also apply to physical therapists who provide services in certain health professional shortage areas. https://www.congress.gov/114/plaws/publ255/PLAW-114publ255.pdf

15

PARA Weekly eJournal: February 26, 2020

GUIDELINES FOR LOCUM TENENS AND RECIPROCAL BILLING

The NPI and services provided by a substitute physician must on file and available upon request.

Medicare contractors offer additional information on billing for locum tenens and reciprocal billing.

Noridian: https://med.noridianmedicare.com/web/jfb/specialties/locum-tenens-and-reciprocal-billing

Novitas: https://www.novitas-solutions.com/webcenter/portal/MedicareJL/pagebyid?contentId=00105762

CGS: https://www.cgsmedicare.com/partb/ pubs/news/2013/0313/cope21500.pdf

16

PARA Weekly eJournal: February 26, 2020

17

PARA Weekly eJournal: February 26, 2020

18

PARA Weekly eJournal: February 26, 2020

19

PARA Weekly eJournal: February 26, 2020

20

PARA Weekly eJournal: February 26, 2020

21

PARA Weekly eJournal: February 26, 2020

22

PARA Weekly eJournal: February 26, 2020

Dow n load t h e PDF ver sion by click in g t h e im age above.

23

PARA Weekly eJournal: February 26, 2020

DEVICE CATEGORY CODES FOR PASS-THROUGH PAYMENTS

CMS has published its 2020 list of HCPCS codes for devices which are, or have been, separately reimbursed under OPPS with pass-through payment. This year, there are five new codes, which are described later in this document.

Innovative devices may be granted a pass-through payment status for up to 3 years while allowing CMS to collect cost data. The list of C-codes, which includes their definitions and expiration dates, is available on the PARA Data Editor Advisor tab.

Enter ?device? in the Summary field. (see below) When a claim includes a pass-through device (status G or H) a payment for the device is made in addition to the payment for the surgical procedure. OPPS hospitals are required to report the device codes with the procedures even when the pass-through status has expired. Once a device category expires, the cost of the device is included in the APC rate for the procedure.

Although the CMS HCPCS list appears to be complete, CMS has added a disclaimer that the device category list does not include all OPPS reportable device HCPCS codes.

Chapter 4, Section 61.1 of the Medicare Claims Processing Manual, Requirement that Hospitals Report Device Codes on Claims on Which They Report Specific Procedures provides additional information to OPPS hospitals on reporting and satisfying edits on devices.

https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104c04.pdf

24

PARA Weekly eJournal: February 26, 2020

DEVICE CATEGORY CODES FOR PASS-THROUGH PAYMENTS

The CMS file also provides more expansive definitions of some device category codes.For example, CMS provides an updated description on one of the most commonly reported C-Codes, C1713 implantable anchor/screw for opposing bone-to-bone, or soft tissue to bone:

The five codes added in 2020, along with the product each of the codes represent, are provided below: C1734-Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable) AUGMENT® Bone Graft, an alternative to autograft in arthrodesis of the ankle and/or hindfoot where the need for supplemental graft material is required. The applicant stated that the product has two components: human platelet-derived growth factor and Beta-tricalcium phosphate granules.

The two components are combined at the point of use and applied to the surgical site. https://www.wrightemedia.com/ProductFiles/Files/ PDFs/LBS104_EN_LR_LE.pdf C2596 ? Probe, image-guided, robotic, waterjet ablation AquaBeam® Robotic System (CPT® 0421T),system resects the prostate to relieve symptoms of urethral compression. The resection is performed robotically using a high velocity, non-heated sterile saline water jet (in a procedure called Aquablation).

https://www.procept-biorobotics.com/aquabeam-surgical-robotic-system/#section-aquablation-procedure

25

PARA Weekly eJournal: February 26, 2020

DEVICE CATEGORY CODES FOR PASS-THROUGH PAYMENTS

C1982 - Catheter, pressure-generating, one-way valve, intermittently occlusive Surefire® Spark Infusion System, a flexible, ultra-thin microcatheter with a self-expanding, nonocclusive one-way microvalve at the distal end. The technology improves distribution and penetration of therapy during Transcatheter Arterial Chemoembolization (TACE) procedures. https://surefireinfusion.com C1824 - Generator, cardiac contractility modulation (implantable) Optimizer® Smart System, an implantable device that delivers Cardiac Contractility Modulation (CCM) therapy for the treatment of patients with moderate to severe chronic heart failure. https://www.impulse-dynamics.com/us/?cr=1

C1839 ? Iris Prosthesis CustomFlex® Artificial Iris, an iris prosthesis for the treatment of iris defects. https://www.humanoptics.com/en/physicians/artificialiris/

26

PARA Weekly eJournal: February 26, 2020

2020 COVERAGE FOR EXTRAVASCULAR ICD CLINICAL TRIAL CLAIMS

M edicar e h as an n ou n ced an u pdat e t o t h e 2020 OPPS Fin al Ru le r elat in g t o Ext r avascu lar Im plan t able Car diover t er Def ibr illat or s.

https://www.cms.gov/files/document/mm11605.pdf 19. Ext r avascu lar Im plan t able Car diover t er Defibrillator (EV ICD)In the

CY 2020 OPPS/ASC final rule that was published in the Federal Register on November 12, 2019, we stated that CPT codes 0571T through 0580T, which were effective January 1, 2020, would be assigned to OPPS status indicator "E1" to indicate that the codes are not payable by Medicare because the clinical trial associated with the codes has not met Medicare's standards for coverage. We further stated that if Medicare approved the EV ICD clinical trial for coverage, we would reassess the SI and APC assignments for the codes.

27

PARA Weekly eJournal: February 26, 2020

2020 COVERAGE FOR EXTRAVASCULAR ICD CLINICAL TRIAL CLAIMS

Since the publication of the CY 2020 OPPS/ASC final rule, the EV ICD clinical study was approved by CMS for Medicare coverage on December 4, 2019 as a Category B IDE study. Therefore, we have revised the OPPS status indicator and APC assignments for the codes for the January 2020 update.

Table 14 shows the status indicator and APC assignments for CPT® codes 0571T through 0580T. The payment rates for CPT® codes 0571T through 0580T can be found in Addendum B of the January 2020 OPPS Update that is posted on the CMS website.

Table 14 -- Extravascular Implantable Cardioverter Defibrillator (EV ICD) Effective January 1, 2020

28

PARA Weekly eJournal: February 26, 2020

2020 COVERAGE FOR EXTRAVASCULAR ICD CLINICAL TRIAL CLAIMS

Links and excerpts to other CMS publications regarding Investigation Device Exemption Category B studies appear below.

The rules relating to IDE Category B studies are discussed at the following link (excerpt provided.) https://www.cms.gov/Medicare/Coverage/IDE M edicar e Cover age Relat ed t o In vest igat ion al Device Exem pt ion (IDE) St u dies

Instructions: Medicare Coverage Related to Investigational Device Exemption (IDE) Studies The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) allowed Medicare payment of the routine costs of care furnished to Medicare beneficiaries in certain categories of Investigational Device Exemption (IDE) studies. Covering the costs in these IDE studies removes a financial barrier that could otherwise discourage beneficiaries from participating.

CMS finalized changes to the IDE regulations (42 CFR ยง 405 Subpart B), effective January 1, 2015.

CMS added criteria for coverage of IDE studies and changed from local Medicare Administrative Contractor (MAC) review and approval of IDE studies to a centralized review and approval of IDE studies. An approval for a Category A (Experimental) IDE study will allow coverage of routine care items and services furnished in the study, but not of the Category A device, which is statutorily excluded from coverage.An approval for a Category B (Nonexperimental/investigational) IDE study will allow coverage of the Category B device and the routine care items and services in the trial.

IDE studies approved by MACs prior to January 1, 2015 will continue to be administered by the MAC.Study sponsors do not have to submit the protocol to CMS if the participating study investigator sites have already received approval from their MAC. Study sponsors should continue to follow the process established by the MAC for any site additions or protocol changes.Click on this link to find a list of MACs: https://www.cms.gov/Medicare/Medicare-Contracting/Medicare-Administrative -Contractors/MACJurisdictions Further details about billing requirements are available in the MLN Matters article here: https://www.cms.gov/Medicare/Coverage/IDE/Downloads/MM8921pdf.pdf 29

PARA Weekly eJournal: February 26, 2020

i v e st l e th ! Ju e r s s e s m i o r r i e gi st g u y o N o w l e, r r d i n d i c o D r? ec o u r s ci r a r e n bi t h v e a 72 h w e on t. ha hin k l n l c ' t e i i cl w e l e w e ev d an i l ab e l i v a th av of

30

PARA Weekly eJournal: February 26, 2020

CODING FOR CORONAVIRUS

Cor on avir u ses are classified as a large family of viruses that cause infection in the sinuses, nose and upper throat. Some coronaviruses cause illness in people and others circulate among animals, including camels, cats and bats.

The 2019 Novel Coronavirus (2019-nCoV) is a new form of coronavirus first identified in Wuhan, Hubei Province, China.

The 2019-nCoV continues to expand with growing numbers of illness in people in multiple countries, including recent confirmation in the United States.The CDC is currently closely monitoring the outbreak of the 2019-nCoV respiratory illness.

Clinical indications of the virus include early symptoms of fever, cough and shortness of breath. The CDC reported, ?Symptoms may appear in as few as 2 days or as long as 14 after exposure ?.

When coding for the coronavirus, report ICD-10 CM code B34.2, Coronavirus infection, unspecified. Refer to the PARA Data Editor code description:

Diagnosis codes B97.21 and B97.29 would not be appropriate for the 2019-nCoV.The B97.2- ICD-10 CM category is classified as a ?viral agent as the cause of other diseases? and only identifies the organism not the virus. Refer to the Official Coding Guidelines Section I.C.1.b found in the PARA Data Editor Calculator which discusses category B97.- and the PARA Data Editor code descriptions.

31

PARA Weekly eJournal: February 26, 2020

CODING FOR CORONAVIRUS

2020 Official Coding Guidelines - Section I.C.1.b ? B97, Viral agents as the cause of diseases classified to other chapters, is to be used as an additional code to identify the organism. An instructional note will be found at the infection code advising that an additional organism code is required.ICD-10 CM code J12.81 would not be appropriate for 2019-nCoV even if the patient develops pneumonia.ICD-10 CM defines J12.81 as Pneumonia due to SARS-associated coronavirus. The 2019-nCoV has not been confirmed as SARS (Severe Acute Respiratory Syndrome) associated coronavirus.

The CDC reported that the 2019-nCoV is likely spread person to person via respiratory droplets when the infected person coughs or sneezes.There is much more to learn about the transmissibility, severity, and other features associated with 2019-nCoV and investigations are ongoing. https://www.cdc.gov/coronavirus/2019-ncov/index.html There is currently no vaccine to prevent 2019-nCoV infection. The best way to prevent infection is to avoid being exposed to this virus. However, as a reminder, CDC always recommends everyday preventive actions to help prevent the spread of respiratory viruses, including: - Wash your hands often with soap and water for at least 20 seconds.

- Use an alcohol-based hand sanitizer that contains at least 60% alcohol if soap and water are not available.

- Avoid touching your eyes, nose, and mouth with unwashed hands.

- Avoid close contact with people who are sick.

- Stay home when you are sick.

- Cover your cough or sneeze with a tissue, then throw the tissue in the trash.Clean and disinfect frequently touched objects and surfaces.

32

PARA Weekly eJournal: February 26, 2020

NEW 2020 CCI EDITS TO BE REVERSED

Af t er r eceivin g a n u m ber of ?adver se com m en t s?, M edicar e?s n ew CCI Edit con t r act or , Capit ol Br idge, LLC, w ill r ever se a n u m ber of t r ou blesom e CCI edit s t h at becam e ef f ect ive 1/ 1/ 2020.

The contractor intends to remove the edits retroactive to 1/1/2020, although as a practical matter the edits will still cause claims to reject until the claims processing files used by MACs can be corrected.The relaxed edits will include: - Nuclear medicine tests billed together with a radiopharmaceutical, (i.e. 78306 with A9503) - Barium swallow testing (92611 with 74230); - And PT/OT evaluations (97161-97163 and 97165-97168) billed on the same DOS as therapeutic activities (97530) (as reported by the American Physical Therapy Association and the American Occupational Therapy Association in late January.) The Medicare Outpatient Code Editor, which includes NCCI edits and MUE values, is updated on a quarterly basis.The next scheduled update is 4/1/2020.

33

PARA Weekly eJournal: February 26, 2020

NEW 2020 CCI EDITS TO BE REVERSED

Nuclear Medicine & Barium Swallow Edits PARA received an email from Capitol Bridge, LLC on Friday, January 31, 2020 acknowledging the nuclear medicine and barium swallow CCI edit changes. The text of that email is provided below: From : N CCI <N CCIM ailbox@capitolbridgellc.com> Sent: Friday, January 31, 2020 1:02 PM Subject: R E: N ew CCI Edits for N uc M ed Procedures T hank you for your inquiry regarding the N ational Correct Coding Initiative (N CCI) program. T he Centers for M edicare & M edicaid Services (CM S) owns the N CCI program and is responsible for all decisions regarding its contents.

In your correspondence, you inquired about the recent implementation of certain Procedure-to-Procedure (PT P) edits related to N uclear M edicine and Diagnostic R adiology.After reviewing this issue more closely, CM S has made the decision to delete the following January 1, 2020 PT P edits:

CM S will change the Practitioner (PR A) and O utpatient H ospital (OPH ) M odifier indicator for the following January 1, 2020 PT P edit:

34

PARA Weekly eJournal: February 26, 2020

NEW 2020 CCI EDITS TO BE REVERSED

Both of these changes will be retroactive to January 1, 2020 and will be implemented as soon as technically possible in a future edit update. T he update will be available at the following websites: M edicare: https://www.cms.gov/M edicare/Coding/N ationalCorrectCodInitEd/Version_U pdate_Changes.html M edicaid: https://www.medicaid.gov/medicaid/program-integrity/ncci/edit-files/index.html Providers may choose to delay submission of claims for deleted edits until after the implementation of the replacement edit file with retroactive date of January 1, 2020. Providers may also choose to appeal claims denied due to the PT P edits to the appropriate M AC including supporting documentation or resubmit claims denied due to the PT P edits after the implementation of the replacement edit file with January 1, 2020 retroactive date, as permitted by the M AC.CM S and the N CCI Program appreciate your time in making this inquiry.

Sincerely, Capitol Bridge, LLC N ational Correct Coding Initiative Contractor Email:N CCIPT PM U E@cms.hhs.gov P.O. Box 368 Pittsboro, IN 46167 SBA Cer tified 8(a) Sm all D isadvant aged Business

Therapy Evaluation with Therapeutic Activities ?In late January, both the American Occupational Therapy Association and the American Physical Therapy Association announced that Medicare will roll back the CCI edit between the therapy evaluation codes (97161-97163, 97165-97168) and therapeutic activities, 97530.

PARA was not a party to the correspondence from Medicare that indicated this change.See PARA?s paper on this topic at: https://apps.para-hcfs.com/para/Documents/CMS% 20May%20Reverse%202020%20CCI%20Edits%20for %20PT%20OT%20Services.pdf

35

PARA Weekly eJournal: February 26, 2020

BILLING DEVICE-INTENSIVE HCPCS WITHOUT A DEVICE

IN THE 2020 OPPS UPDATE M LN ARTICLE Medicare repeated little-known news about modifier CG that was quietly introduced in the October, 2019 Integrated Outpatient Code Editor update file.The guidance instructs hospitals to append modifier CG ? ?Policy criteria applied? ? when reporting a device-dependent outpatient procedure which did not require a device.

The OPPS guidance is retroactive to January 1, 2019, although it was first included in the October 2019 update of the Integrated Outpatient Code Editor.

Many hospitals were advised by their MAC to report a device code at a nominal value to resolve the edit preventing claim submission without the device reported.Hospitals which may have reported a device-intensive procedure in 2019 which did not require a device should consider submitting a corrected claim with modifier CG, rather than device codes with a nominal value.

Here?s an excerpt from Medicare?s January 2020 Update of the Hospital Outpatient Prospective Payment System (OPPS): https://apps.para-hcfs.com/PDE_V2/CDMEditor_New.aspx

The edit to be bypassed is IOCE edit 92:

36

PARA Weekly eJournal: February 26, 2020

BILLING DEVICE-INTENSIVE HCPCS WITHOUT A DEVICE

Background In the January 2019 OPPS update, Medicare nearly doubled the number of HCPCS on OPPS Addendum P ? ?Device Intensive Procedures? -- procedures for which CMS has determined at least 30% of the APC payment is attributed to a packaged device code. Addendum P lists the percentage by which CMS will reduce payment -- an ?offset percentage? ? to the OPPS hospital if the hospital does not incur the expected cost of an implant.

While CMS has long provided instructions for reporting a reduced-cost implant, it had not provided instructions for situations in which no implant at all was needed. Billers were unable to resolve edit 92 without including an implant on the claim, even if no implant at all was used for the procedure.

OPPS Addendum P, which is available on the PARA Data Editor Advisor tab ? bear in mind that CMS may publish changes to this addendum quarterly:

Since some of the HCPCS listed on the OPPS Addendum P ?Device-Intensive Procedures? do not always require a device, hospitals previously had no appropriate mechanism to report such procedures. Some hospitals were verbally advised by their MAC to report a device anyway, at a very nominal price (e.g., $1.00.) However, this billing method could result in full payment of the APC, when reduced payment should have been paid.

Modifier CG is not a new modifier. It is also used by dialysis providers and Rural Health Clinics for completely different purposes. Now, modifier CG has a third application. It may also be reported by OPPS hospitals when billing certain device-dependent procedures (which required no device) on an outpatient claim.

For example, HCPCS 27443 (ARTHROPLASTY, FEMORAL CONDYLES OR TIBIAL PLATEAU(S), KNEE; WITH DEBRIDEMENT AND PARTIAL SYNOVECTOMY) may involve either realigning the joint or replacing it with a prosthetic one.

Therefore, this HCPCS may be reported either a procedure which requires an implant or one which does not.Since 27443 appears on the OPPS list of ?device-dependent procedures in Addendum P, claims in 2019 were not accepted unless a device was also reported on the claim.

37

PARA Weekly eJournal: February 26, 2020

BILLING DEVICE-INTENSIVE HCPCS WITHOUT A DEVICE

If the hospital used no implant, or a significantly reduced cost implant, a lower APC reimbursement rate should be paid, according to the ?Device Offset Amount? indicated in Addendum P. Here is an excerpt from Addendum P which indicates that the APC reimbursement for HCPCS 27443 will be reduced by $4,972.76 (unadjusted national average) when reported with modifier CG appended, or when the implant is reported at a significantly reduced cost to the hospital.

For more information on claims submission requirements for reduced cost implants, see PARA?s paper at https://apps.para-hcfs.com/para/Documents/Reporting_Manufacturer_Credit_for_Devices_edited.pdf 38

PARA Weekly eJournal: February 26, 2020

SIX STEPS FOR DEPLOYING AI SOLUTIONS IN DENIAL MANAGEMENT

Resolu t ion | Recover y | M an agem en t HFRI is altering the hospital AR landscape by delivering unparalleled speed, scalability and accuracy to the insurance AR management process. Through our proprietary, intelligent automation and powerful process engineering, we?re able to resolve all claims, regardless of size or age. That means you?re able to recover collections from insurance claims that otherwise would have been written off.

Our AR management services are easily integrated into your hospital?s existing workflow to seamlessly function as an extension to your existing billing office. HFRI specialists collaborate with your team not only to assist with your denial management initiatives but to identify root causes that will help prevent denials from occurring in the first place.

Specialized Services to Improve AR Performance HFRI?s scalable, client-specific solutions allow hospitals to systematically address problem claims across the full AR spectrum, from government and commercial payers to managed care, worker?s compensation and personal injury claims.

Our capabilities include: - Primary AR recovery and resolution We pursue aging, small-balance claims identified by your staff as problematic. If a claim has previously been worked internally, referring it to HFRI?s dedicated, specialized teams can help ensure quicker cash conversion and a reduction of bad debt reserves.

- Pre write-off AR recovery and resolution In addition to primary AR recovery and management services, HFRI also offers pre write-off (often known as secondary) insurance AR recovery to help you collect highly-aged claims and minimize write-offs.

- Legacy system conversions Transitioning to a new system can slow down the claims process and create problems for hospital personnel who must work between two billing platforms. HFRI can provide interim solutions to help you accelerate pre-conversion cash and assist with post-conversion AR resolution. AR recovery projects: HFRI is available to assist you on a temporary project basis to address AR backlogs that can?t be worked by your existing staff.

39

PARA Weekly eJournal: February 26, 2020

PAYMENT DENIALS COST MONEY. HOW TO MAXIMIZE COLLECTIONS

O r d er - O f - I n su r an ce D en i al s C an C o st M o n ey A n d U n d er m i n e T h e Pat i en t Ex p er i en ce.

When it comes to payment denials, some of the most common and potentially damaging involve Claim Adjustment Reason Code (CARC) 22, or order-of-insurance coverage problems.

Not only do CARC 22 denials reduce cash flow, they can also trigger unnecessary patient invoicing. This, in turn, may undermine customer goodwill and harm the hospital?s overall patient experience and brand.

To maximize collections and avoid antagonizing patients, organizations should develop procedures for addressing the root causes that lead to CARC 22s. The good news is that once the core issues are identified, avoiding the denials isn?t difficult.

Increasing cash flow Claim Adjustment Reason Codes are used by all payers on electronic and paper remittance advice and coordination of benefit (COB) claim transactions to categorize payment adjustments and denials.CARC-22 states: ?This care may be covered by another payer per coordination of benefits.? In essence, a CARC-22 is generated when a COB-related problem occurs.

A common example involves instances in which the patient?s secondary insurance coverage is being billed as the primary coverage. This can occur with Medicare, Medicare Advantage, Medicaid or a commercial payer as the primary insurer. Typically, the patient is automatically balance-billed following a CARC-22 denial.

From our experience with clients nationwide, Healthcare Financial Resources (HFRI) has found that CARC 22 order-of-insurance denials typically account for about 7-8% of all hospital denials. With average balances generally of between $500 and $1,500 per claim, preventing CARC-22s could mean an additional $100,000 to $1 million in monthly collections, depending on the hospital?s size.

Denial triggers While CARC-22s occur in both inpatient and outpatient settings, the denials are most frequently associated with emergency department services. This is largely due to the fact that staff may not have the time or the systems in place to positively identify the patient?s primary insurance, or the patient may not be in a condition to provide the required information.

40

PARA Weekly eJournal: February 26, 2020

PAYMENT DENIALS COST MONEY. HOW TO MAXIMIZE COLLECTIONS

Specific CARC-22 triggers can include: - Incorrect plan codes loaded for primary insurance - Failed transfer in the attachment of the primary EOB to the bill Medicare CARC-22s may also result from situations in which the beneficiary?s spouse has an employer-based health plan. For example, if the spouse?s employer has 20 or more employees, the group health plan pays first. However, if the employer has less than 20 employees, Medicare is the primary coverage.

Rules regarding other primary payer scenarios involving Medicare and Medicaid, Tricare and workers compensation claims vary.

Detailed information about Medicare and coordination of benefits can be found here.

Reducing denials Registration staff represent the first line of defense when it comes to reducing and eliminating CARC-22s, particularly in the emergency department. Organizations should ensure that systems are in place to verify the correct order of insurance and plan code prior to billing. Staff should also have direct access to state-based websites in order to effectively validate Medicare and Medicaid order of coverage.

Creating an aftercare department to double-check the billing information provides an important second line of defense.

Additionally, third-party robotic process automation systems can be deployed to identify registration issues that could trigger a CARC-22.

Partnering with a vendor Because CARC 22 denials typically involve low-value, high-volume claims, many hospitals ignore them to focus limited resources on other, higher-value denial areas. However, HFRI is equipped to handle these kinds of claims using our advanced technology, which relies on robotic process automation or bots and intelligent automation to identify potential CARC denials and flag them in the workflow.

This helps ensure that any denial issues will to be worked quickly. That means hospitals can receive faster reimbursement and, when necessary, generate the patient bill sooner. Our approach not only improves hospital margins, it helps ensure patient satisfaction doesn?t suffer due to unnecessary, surprise bills.HFRI has focused exclusively on the challenges associated with hospital payment delay and denials for nearly 20 years.

From this effort, we?ve perfected a system that relies on advanced technology and staff specialization to identify denial root causes while streamlining and accelerating the resolution process.

Contact us today to learn more.

41

PARA Weekly eJournal: February 26, 2020

PDE PRICING DATA REPORT -- APC CLAIM ANALYSIS

Hospitals often express an interest in the billing practices of hospitals aligned with their geographic market group. The APC Claim Analysis ad hoc report provides CMS claims data on surgical or significant diagnostic procedures to create a comparative analysis of your hospital?s data to the national norm.

The report lists the HCPCS code requested with its APC Reimbursement. The report then provides APC status and reimbursement for each of the procedures, drugs, and supplies found on other claims with that HCPCS code. The percentages listed in the Hospital Peer Group and the National columns indicate how often a procedure was billed with the HCPCS code that was requested.

Only separately payable OPPS codes will return results. These consist of status J1, J2 and T codes. Other codes such as status N (not separately paid under OPPS), or status Q1, Q2, Q3, or Q4 (paid or packaged under OPPS) and status A (paid on the Physician Fee Schedule, such as physical therapy services) will not return results.

As an example, please see the snippet of the report requesting information on HCPCS 93458 catheter placement in coronary artery(s) for coronary angiography, C1769 Guide Wire, was reported on 100% of the claims within the hospital?s peer group and 77% nationally. Likewise, hospitals within the peer group reported J1644 Injection, Heparin Sodium, 1000 units on 100% and nationally hospitals reported the

42

PARA Weekly eJournal: February 26, 2020

PDE PRICING DATA REPORT -- APC CLAIM ANALYSIS

J1644 72.2% of the time. The report can be formatted in PDF or in Excel; a sample of the PDF version is provided below.

The report can be run with different market groups by using the drop-down in Pricing Group in the lower left corner of the Pricing Data tab.

Hospitals should exercise caution interpreting this data. This report provides information on billing practices that are common for hospitals outpatient claims submitted to Medicare ? common billing practices are not necessarily compliant billing practices.

43

PARA Weekly eJournal: February 26, 2020

NEW YEAR'S RESOLUTION #1: GET PDE FIT

New PDE training opportunities available.

In an effort to streamline the PARA Dat a Edit or (PDE) training process, PARA will begin hosting weekly Overviews of the PDE. These sessions will be open to any client or user who wishes to join, and will consist of a high-level review of the functionality available within the PDE. If you are new to the PDE, or would like a refresher on its capabilities, please join us at whichever session is most convenient for you.

Beginning January 8, 2020 Overview sessions will be held: Wedn esdays at 11:00 am Pacif ic t im e (12:00 pm M ou n t ain , 1:00 pm Cen t r al, 2:00 pm East er n ) Fr idays 8:00 am Pacif ic t im e (9:00 am M ou n t ain , 10:00 am Cen t r al, 11:00 am East er n ) Please note, focused training for your staff on the modules of the PDE that you choose to utilize will still be available.

If you are interested in attending one of the sessions, please email Mary McDonnell, Director of PDE Training and Development at mmcdonnell@para-hcfs.com . An invitation to the session of your choice will be emailed to you. If you have any questions, please email us at the address above or call (800) 999-3332 ext. 216.

44

PARA Weekly eJournal: February 26, 2020

MLN CONNECTS PARA invites you to check out the mlnconnects page available from the Centers For Medicare and Medicaid (CMS). It's chock full of news and information, training opportunities, events and more! Each week PARA will bring you the latest news and links to available resources. Click each link for the PDF!

Th u r sday, Febr u ar y 20, 2020 New s

··CMS Develops New Code for Coronavirus Lab Test ·CMS Program Statistics: 2018 Data ·Medicare Diabetes Prevention Program: Become a Medicare Enrolled Supplier Com plian ce

·Bill Correctly for Medicare Telehealth Services Even t s

·Dementia Care: CMS Toolkits Call ? March 3 ·Part A Providers: QIC Appeals Demonstration Call ? March 5 ·Ground Ambulance Organizations: Data Collection for Public Safety-Based Organizations Call ? March 12 ·Open Payments: Your Role in Health Care Transparency Call ? March 19 M LN M at t er s® Ar t icles

·The Role of Therapy under the Home Health Patient-Driven Groupings Model (PDGM) ·Second Update to CR 11152 Implementation of the Skilled Nursing Facility (SNF) Patient Driven Payment Model (PDPM) ·New Medicare Beneficiary Identifier (MBI) Get It, Use It ? Revised ·What New Home Health Agencies (HHAs) Need to Know about Being Placed in a Provisional Period of Enhanced Oversight ? Revised ·International Classification of Diseases, 10th Revision (ICD-10) and Other Coding Revisions to National Coverage Determination (NCDs) - April 2020 Update ? Revised Pu blicat ion s

·Administrative Simplification: EFT and ERA Transactions View this edition as a PDF (PDF)

45

PARA Weekly eJournal: February 26, 2020

There were THREE new or revised MedLearns released this week.

To go to the full Transmittal document simply click on the screen shot or the link.

3

FIND ALL THESE TRANSMITTALS IN THE ADVISOR TAB OF THE PDE

46

PARA Weekly eJournal: February 26, 2020

The link to this MedLearn MM11638

47

PARA Weekly eJournal: February 26, 2020

The link to this MedLearn MM11655

48

PARA Weekly eJournal: February 26, 2020

The link to this MedLearn MM11652

49

PARA Weekly eJournal: February 26, 2020

There were SEVEN new or revised Transmittals released this week.

To go to the full Transmittal document simply click on the screen shot or the link.

7

FIND ALL THESE TRANSMITTALS IN THE ADVISOR TAB OF THE PDE

50

PARA Weekly eJournal: February 26, 2020

The link to this Transmittal R2438OTN

51

PARA Weekly eJournal: February 26, 2020

The link to this Transmittal R200SOMA

52

PARA Weekly eJournal: February 26, 2020

The link to this Transmittal R4534CP

53

PARA Weekly eJournal: February 26, 2020

The link to this Transmittal R9431PI

54

PARA Weekly eJournal: February 26, 2020

The link to this Transmittal R4536CP

55

PARA Weekly eJournal: February 26, 2020

The link to this Transmittal 2439OTN

56

PARA Weekly eJournal: February 26, 2020

The link to this Transmittal R4533CP

57

PARA Weekly eJournal: February 26, 2020

Con t act Ou r Team

Peter Ripper

M onica Lelevich

Randi Brantner

President

Director Audit Services

Director Financial Analytics

m lelevich@para-hcfs.com

rbrantner@para-hcfs.com

pripper@para-hcfs.com

Violet Archuleta-Chiu Senior Account Executive

Sandra LaPlace

Steve M aldonado

Account Executive

Director Marketing

slaplace@para-hcfs.com

smaldonado@para-hcfs.com

varchuleta@para-hcfs.com

In t r odu cin g, ou r n ew par t n er .

Nikki Graves

Sonya Sestili

Deann M ay

Senior Revenue Cycle Consultant

Chargemaster Client Manager

h f r Review i.n et Claim Specialist

ngraves@para-hcfs.com

ssestili@para-hcfs.com

dmay@para-hcfs.com

M ary M cDonnell

Patti Lew is

Director, PDE Training & Development

Director Business Operations

mmcdonnell@para-hcfs.com

plewis@para-hcfs.com

58